Drug development is a complicated and lengthy process requiring a significant amount of intellectual and capital input, as well as extensive collaborations among various organizations and institutions. Contract research organizations play important roles at some or even all stages of the drug development process. To provide better service in in vitro drug absorption, disposition, metabolism and excretion studies, maintain data accuracy and promote work efficiency, we developed an integrated information system termed the ‘Drug Metabolism Information System’, and it is being used routinely by our drug metabolism department. The Drug Metabolism Information System assists scientists with assay design, data analysis and report drafting and thus reduces human error.

Tweetable abstract

To provide better service in in vitro drug absorption, disposition, metabolism and excretion studies; maintain data accuracy; and promote work efficiency we developed an integrated information system termed the ‘Drug Metabolism Information System’, which is being used routinely by our drug metabolism department.

Keywords:

References

1. Chen J, Luo X, Qiu H, Mackey V, Sun L, Ouyang X. Drug discovery and drug marketing with the critical roles of modern administration. Am. J. Transl. Res. 10(12), 4302–4312 (2018).
Medline CASGoogle Scholar
2. Mirowski P, Van Horn R. The contract research organization and the commercialization of scientific research. Soc. Stud. Sci. 35(4), 503–548 (2005).
MedlineGoogle Scholar
3. Clark GT. HT-ADME in a contract research organization laboratory: can you ensure bioanalytical quality in a highly automated environment? Bioanalysis 7(4), 403–406 (2015).
CASGoogle Scholar
4. Jayashree B, Reddy PT, Leeladevi Y et al. Laboratory information management software for genotyping workflows: applications in high throughput crop genotyping. BMC Bioinformatics 7, 383 (2006).
Medline CASGoogle Scholar
5. Nestor M, Pariser D, Del Rosso J et al. The future of contract research organizations in dermatology and aesthetic research. J. Clin. Aesthet. Dermatol. 15(9), 16–19 (2022).
MedlineGoogle Scholar
6. Giles J. Going paperless: the digital lab. Nature 481(7382), 430–431 (2012).
Medline CASGoogle Scholar
7. Wang Y, Jadhav A, Southal N, Huang R, Nguyen DT. A grid algorithm for high throughput fitting of dose-response curve data. Curr. Chem. Genomics 4, 57–66 (2010).
Medline CASGoogle Scholar
8. Meng M, Wang L, Voelker T, Reuschel S, Van Horne KC, Bennett P. A systematic approach for developing a robust LC–MS/MS method for bioanalysis. Bioanalysis 5(1), 91–115 (2013).
CASGoogle Scholar
9. Unger S, Lloyd T, Tan M, Hou J, Wells E. The science of laboratory and project management in regulated bioanalysis. Bioanalysis 6(10), 1357–1372 (2014).
CASGoogle Scholar
10. Wong SG, Ramsden D, Dallas S et al. Considerations from the Innovation and Quality Induction Working Group in response to drug-drug interaction guidance from regulatory agencies: guidelines on model fitting and recommendations on time course for in vitro cytochrome P450 induction studies including impact on drug interaction risk assessment. Drug Metab. Dispos. 49(1), 94–110 (2021).
Medline CASGoogle Scholar
11. Zimmer D. Outsourcing strategy: local versus international contract research organizations. Bioanalysis 6(10), 1279–1281 (2014).
CASGoogle Scholar

Vol. 15, No. 3

Supplemental Materials

Metrics

Downloaded 165 times

History

Received 4 November 2022

Accepted 7 March 2023

Published online 30 March 2023

Published in print February 2023

Information

Keywords

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.future-science.com/doi/suppl/10.4155/bio-2022-0211

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.

No writing assistance was utilized in the production of this manuscript.

Ethical conduct of research

The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.

PDF download